Search Results - "Sikka, Arti"

Indisulam targets RNA splicing and metabolism to serve as a therapeutic strategy for high-risk neuroblastoma by Nijhuis, Anke, Sikka, Arti, Yogev, Orli, Herendi, Lili, Balcells, Cristina, Ma, Yurui, Poon, Evon, Eckold, Clare, Valbuena, Gabriel N., Xu, Yuewei, Liu, Yusong, da Costa, Barbara Martins, Gruet, Michael, Wickremesinghe, Chiharu, Benito, Adrian, Kramer, Holger, Montoya, Alex, Carling, David, Want, Elizabeth J., Jamin, Yann, Chesler, Louis, Keun, Hector C.

“…Neuroblastoma is the most common paediatric solid tumour and prognosis remains poor for high-risk cases despite the use of multimodal treatment. Analysis of…”
Get full text

Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and Burkitt lymphoma by Noble, Richard A, Bell, Natalie, Blair, Helen, Sikka, Arti, Thomas, Huw, Phillips, Nicole, Nakjang, Sirintra, Miwa, Satomi, Crossland, Rachel, Rand, Vikki, Televantou, Despina, Long, Anna, Keun, Hector C, Bacon, Chris M, Bomken, Simon, Critchlow, Susan E, Wedge, Stephen R

“…Inhibition of monocarboxylate transporter 1 has been proposed as a therapeutic approach to perturb lactate shuttling in tumor cells that lack monocarboxylate…”
Get full text

p53 Loss in MYC-Driven Neuroblastoma Leads to Metabolic Adaptations Supporting Radioresistance by Yogev, Orli, Barker, Karen, Sikka, Arti, Almeida, Gilberto S, Hallsworth, Albert, Smith, Laura M, Jamin, Yann, Ruddle, Ruth, Koers, Alexander, Webber, Hannah T, Raynaud, Florence I, Popov, Sergey, Jones, Chris, Petrie, Kevin, Robinson, Simon P, Keun, Hector C, Chesler, Louis

“…Neuroblastoma is the most common childhood extracranial solid tumor. In high-risk cases, many of which are characterized by amplification of MYCN, outcome…”
Get full text

Evaluating Imaging Biomarkers of Acquired Resistance to Targeted EGFR Therapy in Xenograft Models of Human Head and Neck Squamous Cell Carcinoma by Baker, Lauren C J, Sikka, Arti, Price, Jonathan M, Boult, Jessica K R, Lepicard, Elise Y, Box, Gary, Jamin, Yann, Spinks, Terry J, Kramer-Marek, Gabriela, Leach, Martin O, Eccles, Suzanne A, Box, Carol, Robinson, Simon P

“…Overexpression of EGFR is a negative prognostic factor in head and neck squamous cell carcinoma (HNSCC). Patients with HNSCC who respond to EGFR-targeted…”
Get full text

Abstract 4459: Evaluating imaging biomarkers of acquired resistance to targeted EGFR therapy in xenograft models of human squamous cell carcinoma of the head and neck (SCCHN) by Baker, Lauren CJ, Box, Carol, Sikka, Arti, Box, Gary, Eccles, Suzanne A., Robinson, Simon P.

“…Abstract Overexpression of EGFR has been identified as a negative prognostic factor in squamous cell carcinoma of the head and neck (SCCHN). Patients with…”
Get full text